Skip to main content

Reactions Weekly

Ausgabe 1/2024

Inhalt (167 Artikel)

Case report

Adalimumab

Case report

Adalimumab/BBIBP-CorV

Case report

Amiodarone/Metoprolol

Case report

Amoxicillin

Case report

Antiepileptic-drugs

Case report

Antihyperlipidaemics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Antineoplastics

Case report

Apixaban/Tozinameran

Case report

Benzylpenicillin

Case report

Brexpiprazole

Case report

Calcium

Case report

Cefepime

Case report

Cefotaxime

Case report

Chlorpromazine

Case report

Dapsone

Case report

Diclofenac

Case report

Disulfiram

Case report

Dronabinol

Case report

EGb-761

Case report

Elasomeran

Case report

Enoxaparin-sodium

Case report

Enoxaparin-sodium

Case report

Epinephrine

Case report

Ezetimibe

Case report

Faricimab

Case report

Flurbiprofen

Case report

Gentamicin

Case report

Golimumab

Case report

GSK-2321138A

Case report

Heparin

Case report

Heparin/Tozinameran

Case report

Hyaluronic-acid

Case report

Hydroxycarbamide

Case report

Immune-globulin

Case report

Interferon-beta-1a

Case report

Iopamidol

Case report

Iopamidol

Case report

Ioversol

Case report

Ipilimumab/Nivolumab

Case report

Ixekizumab

Case report

Lenvatinib

Case report

Levonorgestrel

Case report

Levonorgestrel

Case report

Lidocaine

Case report

Magnesium-sulfate

Case report

Maralixibat

Case report

Mesalazine

Case report

Methotrexate overdose

Case report

Metronidazole

Case report

Mitomycin

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Nandrolone

Case report

Nelarabine

Case report

Nivolumab

Case report

Nivolumab

Case report

Nivolumab

Case report

Nivolumab/paclitaxel

Case report

Ocrelizumab/rituximab

Case report

Olanzapine

Case report

Ondansetron

Case report

Paclitaxel

Case report

Pantoprazole

Case report

Pembrolizumab

Case report

Penicillamine

Case report

Phytomenadione

Case report

Prangos-ferulacea

Case report

Pregabalin

Case report

Propranolol

Case report

Risperidone

Case report

Secukinumab

Case report

Selenium/Vitamins

Case report

Sertraline

Case report

Sintilimab

Case report

Sodium thiosulfate

Case report

Sunitinib

Case report

Tamoxifen

Case report

Tamoxifen

Case report

Tizanidine

Case report

Tozinameran

Case report

Tozinameran

Case report

Tozinameran

Case report

Tozinameran

Case report

Tozinameran

Case report

Vancomycin

Case report

Zoledronic-acid